Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)
Headline News about Calidi Biotherapeutics, Inc. Common Stock
    Dow Surges 100 Points; Target Shares Fall After Q2 Results
    
    August 20, 2025
   
    Calidi Loss Down 23 Percent in Fiscal Q2
    
   August 08, 2025
   Via The Motley Fool
    Topics
      Intellectual Property
    
   
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

